Malkas L H, Hickey R J
Department of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, Baltimore 21201, USA.
Methods Enzymol. 1996;275:133-67. doi: 10.1016/s0076-6879(96)75011-5.
In recent years, work from a large number of laboratories has greatly expanded our knowledge of the biochemical characteristics and the genetic structure of the DNA polymerases used during papovavirus DNA replication. The development of in vitro DNA replication systems for both SV40 and polyoma virus has been paramount in facilitating the development of the current models describing how DNA polymerase alpha and delta function to replicate the genomes of these two viruses. Our studies have demonstrated that the proteins recognized to be essential for both in vitro SV40 and polyoma viral origin-dependent DNA synthesis can be isolated from cells as an intact complex. We have shown that the human cell MRC closely resembles the murine cell MRC, in both its protein composition and its fractionation and chromatographic profile. In addition, our data regarding both the human and the murine MRC support the dipolymerase model proposed from in vitro DNA replication studies using reconstituted assay systems. In addition, analysis of the nucleotide sequence of the genes encoding DNA polymerase alpha and delta has revealed that the amino acids encoded by several regions of these two genes have been rigorously maintained across evolutionary lines. This information has permitted the identification of protein domains which mediate the complex series of protein-protein interactions that direct the DNA polymerases to the cell nucleus, specify complete or partial exonuclease active sites, and participate in the interaction of each DNA polymerase with the DNA template. Expression studies examining each of the genes encoding DNA polymerase alpha and delta clearly indicate that both DNA polymerases are cell cycle regulated and undergo a dramatic induction in their expression when quiescent cells are stimulated to enter the cell cycle. This is in contrast to the two- to three-fold upregulation in the level of expression of these two genes when cycling cells cross the G1/S boundary. In addition, both proteins are phosphorylated in a cell cycle-dependent manner, and phosphorylation appears to be mediated through the action of a cdc2-dependent protein kinase. Despite all of this new information, much remains to be learned about how papovavirus DNA replication is regulated and how these two DNA polymerases act in vivo to faithfully copy the viral genomes. Studies have yet to be performed which identify all of the cellular factors which potentially mediate papovavirus DNA replication. The reconstituted replication systems have yielded a minimum number of proteins which are required to replicate SV40 and polyoma viral genomes in vitro. However, further studies are needed to identify additional factors which may participate in each step of the initiation, elongation, and termination phases of viral genome replication. As an example, models describing the potential role of cellular helicases, which are components of the MRC isolated from murine and human cells, have yet to be described. It is also conceivable that there are a number of other proteins which serve to attach the MRC to the nuclear matrix, stimulate viral DNA replication, and potentially regulate various aspects of the activity of the MRC throughout viral DNA replication. We are currently working toward characterizing the biochemical composition of the MRC from both murine and human cells. Our goals are to identify all of the structural components of the MRC and to define the role of these components in regulating papovavirus and cellular DNA replication. We have also begun studies to visualize the spatial organization of these protein components within the MRC, examine the regulatory processes controlling the activity of the various components of the MRC, and then develop this information into a coherent picture of the higher order structure of the MRC within the cell nucleus. We believe that this information will enable us to develop an accurate view of the detailed processes mediating both pa
近年来,大量实验室的研究极大地拓展了我们对乳头瘤病毒DNA复制过程中所使用的DNA聚合酶的生化特性和遗传结构的认识。SV40和多瘤病毒体外DNA复制系统的发展,对于推动当前描述DNA聚合酶α和δ如何发挥功能以复制这两种病毒基因组的模型的发展至关重要。我们的研究表明,那些被认为对体外SV40和多瘤病毒依赖病毒起源的DNA合成至关重要的蛋白质,可以作为一个完整的复合物从细胞中分离出来。我们已经证明,人类细胞的多酶复制复合物(MRC)在其蛋白质组成、分级分离和色谱图谱方面与小鼠细胞的MRC非常相似。此外,我们关于人类和小鼠MRC的数据支持了使用重组检测系统进行的体外DNA复制研究所提出的双聚合酶模型。此外,对编码DNA聚合酶α和δ的基因的核苷酸序列分析表明,这两个基因几个区域所编码的氨基酸在进化过程中一直被严格保留。这些信息使得人们能够识别出介导一系列复杂的蛋白质 - 蛋白质相互作用的蛋白质结构域,这些相互作用将DNA聚合酶导向细胞核、确定完整或部分核酸外切酶活性位点,并参与每种DNA聚合酶与DNA模板的相互作用。对编码DNA聚合酶α和δ的每个基因的表达研究清楚地表明,这两种DNA聚合酶都受细胞周期调控,并且当静止细胞被刺激进入细胞周期时,它们的表达会发生显著诱导。这与循环细胞越过G1/S边界时这两个基因表达水平上调两到三倍的情况形成对比。此外,这两种蛋白质都以细胞周期依赖性方式被磷酸化,并且磷酸化似乎是通过依赖细胞周期蛋白依赖性激酶2(cdc2)的蛋白激酶的作用介导的。尽管有了所有这些新信息,但关于乳头瘤病毒DNA复制如何被调控以及这两种DNA聚合酶在体内如何忠实地复制病毒基因组,仍有许多有待了解的地方。尚未进行能够识别所有可能介导乳头瘤病毒DNA复制的细胞因子的研究。重组复制系统已经确定了在体外复制SV40和多瘤病毒基因组所需的最少蛋白质数量。然而,需要进一步研究以识别可能参与病毒基因组复制起始、延伸和终止阶段每个步骤的其他因子。例如,描述细胞解旋酶潜在作用的模型尚未被描述,细胞解旋酶是从小鼠和人类细胞中分离出的MRC的组成部分。也可以想象,还有许多其他蛋白质用于将MRC附着到核基质上、刺激病毒DNA复制,并可能在整个病毒DNA复制过程中调节MRC活性的各个方面。我们目前正在努力表征来自小鼠和人类细胞的MRC的生化组成。我们的目标是识别MRC的所有结构成分,并确定这些成分在调节乳头瘤病毒和细胞DNA复制中的作用。我们也已经开始研究以可视化这些蛋白质成分在MRC内的空间组织,研究控制MRC各种成分活性的调节过程,然后将这些信息整合为细胞核内MRC更高阶结构的连贯图像。我们相信这些信息将使我们能够准确地了解介导这两种病毒DNA复制的详细过程。